Stabosz reports 5.5% stake in Hutchinson, urges sale of unit

Timothy Stabosz said in a regulatory filing that he believes Hutchinson's stock price is significantly undervalued based upon a "misunderstanding in the marketplace." Stabosz added that "Hutchinson is in a position where the significant losses of the last several years could be staunched, before long, and the company could realize a major turnaround." Stabosz believes the company should explore a sale of the BioMeasurement division.

View Comments (0)